VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+4.68%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$223M
AUM Growth
-$41.4M
(-16%)
Cap. Flow
-$33.4M
Cap. Flow
% of AUM
-14.95%
Top 10 Holdings %
Top 10 Hldgs %
11%
Holding
420
New
44
Increased
50
Reduced
231
Closed
47
Top Buys
| 1 |
The Mosaic Company
MOS
|
$2.75M |
| 2 |
STR
Sitio Royalties
STR
|
$2.32M |
| 3 |
Copel
ELP
|
$2.31M |
| 4 |
Vale
VALE
|
$2.26M |
| 5 |
Nutrien
NTR
|
$2.24M |
Top Sells
| 1 |
Boise Cascade
BCC
|
$2.62M |
| 2 |
Extra Space Storage
EXR
|
$2.49M |
| 3 |
Canadian Natural Resources
CNQ
|
$2.46M |
| 4 |
Imperial Oil
IMO
|
$2.45M |
| 5 |
Avient
AVNT
|
$2.42M |
Sector Composition
| 1 | Materials | 20.16% |
| 2 | Real Estate | 20.02% |
| 3 | Healthcare | 16.51% |
| 4 | Energy | 10.55% |
| 5 | Utilities | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Syndax Pharmaceuticals
SNDX
$1.47B
| $152K | 0.07% |
8,723
-515
| -6% | -$8.97K |
|
227
Invesco Senior Loan ETF
BKLN
$6.98B
| $148K | 0.07% |
6,820
-2,863
| -30% | -$62.1K |
|
228
Cogent Biosciences
COGT
$1.82B
| $146K | 0.07% |
19,452
-1,158
| -6% | -$8.69K |
|
|
IGMS
229
DELISTED
IGM Biosciences
IGMS
| $146K | 0.07% |
5,469
-318
| -5% | -$8.49K |
|
230
Krystal Biotech
KRYS
$4.35B
| $146K | 0.07% |
2,199
-137
| -6% | -$9.1K |
|
231
Merus
MRUS
$5.1B
| $146K | 0.07% |
5,513
-330
| -6% | -$8.74K |
|
232
Iovance Biotherapeutics
IOVA
$901M
| $144K | 0.06% |
8,663
-519
| -6% | -$8.63K |
|
|
MYOV
233
DELISTED
Myovant Sciences Ltd.
MYOV
| $142K | 0.06% |
10,655
-634
| -6% | -$8.45K |
|
234
Celldex Therapeutics
CLDX
$1.52B
| $141K | 0.06% |
4,131
-251
| -6% | -$8.57K |
|
|
MRNS
235
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $141K | 0.06% |
15,039
-893
| -6% | -$8.37K |
|
236
Atea Pharmaceuticals
AVIR
$267M
| $140K | 0.06% |
19,333
-1,148
| -6% | -$8.31K |
|
237
PMV Pharmaceuticals
PMVP
$77.4M
| $140K | 0.06% |
6,746
-405
| -6% | -$8.41K |
|
|
MORF
238
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $140K | 0.06% |
3,493
-200
| -5% | -$8.02K |
|
239
Crinetics Pharmaceuticals
CRNX
$3.35B
| $139K | 0.06% |
6,346
-380
| -6% | -$8.32K |
|
240
FibroGen
FGEN
$48.9M
| $139K | 0.06% |
462
-27
| -6% | -$8.12K |
|
241
Nkarta
NKTX
$161M
| $138K | 0.06% |
12,126
-717
| -6% | -$8.16K |
|
242
Seres Therapeutics
MCRB
$169M
| $137K | 0.06% |
962
-57
| -6% | -$8.12K |
|
243
Prothena Corp
PRTA
$460M
| $135K | 0.06% |
3,686
-215
| -6% | -$7.87K |
|
|
ITOS
244
DELISTED
iTeos Therapeutics
ITOS
| $134K | 0.06% |
4,161
-251
| -6% | -$8.08K |
|
|
NGM
245
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $134K | 0.06% |
8,782
-519
| -6% | -$7.92K |
|
|
BCYC
246
Bicycle Therapeutics
BCYC
$496M
| $131K | 0.06% |
2,987
-179
| -6% | -$7.85K |
|
247
CRISPR Therapeutics
CRSP
$4.99B
| $131K | 0.06% |
2,081
-122
| -6% | -$7.68K |
|
248
Gossamer Bio
GOSS
$668M
| $131K | 0.06% |
15,039
-893
| -6% | -$7.78K |
|
|
AMRS
249
DELISTED
Amyris Inc.
AMRS
| $130K | 0.06% |
29,766
-1,761
| -6% | -$7.69K |
|
|
SWTX
250
DELISTED
SpringWorks Therapeutics
SWTX
| $129K | 0.06% |
2,288
-137
| -6% | -$7.72K |
|